Amikacin disposition in neonates: validation of a drug clearance population pharmacokinetic model

被引：0
|
作者：
Scheers, I. [1 ]
Anderson, B. J. [2 ]
van den Anker, J. N. [3 ,4 ,5 ]
Cossey, V. [1 ]
Allegaert, K. [1 ]
机构：
[1] Univ Hosp Gasthuisberg, Neonatal Intens Care Unit, B-3000 Louvain, Belgium
[2] Univ Auckland, Dept Anesthesiol, Auckland 1, New Zealand
[3] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA
[4] Childrens Natl Med Ctr, Div Pediat Clin Pharmacol 3, Washington, DC 20010 USA
[5] Sophia Childrens Univ Hosp, Erasmus MC, Dept Pediat 5, Rotterdam, Netherlands
来源：
ACTA PAEDIATRICA | 2007年 / 96卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：16 / 16
页数：1
相关论文
共 50 条
  • [41] A Physiologically Based Pharmacokinetic Model for Optimally Profiling Lamotrigine Disposition and Drug–Drug Interactions
    Todd M. Conner
    Ronald C. Reed
    Tao Zhang
    European Journal of Drug Metabolism and Pharmacokinetics, 2019, 44 : 389 - 408
  • [42] A pharmacokinetic model for analysis of drug disposition profiles undergoing enterohepatic circulation
    Wajima, T
    Yano, Y
    Oguma, T
    JOURNAL OF PHARMACY AND PHARMACOLOGY, 2002, 54 (07) : 929 - 934
  • [43] Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates
    Wei Zhao
    Valérie Biran
    Evelyne Jacqz-Aigrain
    Clinical Pharmacokinetics, 2013, 52 : 1127 - 1134
  • [44] Amikacin Maturation Model as a Marker of Renal Maturation to Predict Glomerular Filtration Rate and Vancomycin Clearance in Neonates
    Zhao, Wei
    Biran, Valerie
    Jacqz-Aigrain, Evelyne
    CLINICAL PHARMACOKINETICS, 2013, 52 (12) : 1127 - 1134
  • [45] ORAL BIOAVAILABILITY AND CLEARANCE OF THE BENZODIAZEPINE MIDAZOLAM FROM PRETERM NEONATES TO ADULTS: A POPULATION PHARMACOKINETIC ANALYSIS
    Ince, I.
    de Wildt, S. N.
    Peeters, M. Y. M.
    Burggraaf, K.
    Jacqz-Aigrain, E.
    Barrett, J. S.
    Danhof, M.
    Knibbe, C. A. J.
    INTENSIVE CARE MEDICINE, 2013, 39 : S151 - S151
  • [46] AN EXTENDED PHYSIOLOGICAL PHARMACOKINETIC MODEL OF METHADONE DISPOSITION IN THE RAT - VALIDATION AND SENSITIVITY ANALYSIS
    GABRIELSSON, JL
    GROTH, T
    JOURNAL OF PHARMACOKINETICS AND BIOPHARMACEUTICS, 1988, 16 (02): : 183 - 201
  • [47] Development of a pharmacokinetic population model for atazanavir on a drug user population
    Guiastrennec, Benjamin
    Forrest, Alan
    Ma, Qing
    Morse, Gene
    PHARMACOTHERAPY, 2012, 32 (05): : E115 - E115
  • [48] Special Section on Transporters in Drug Disposition and Pharmacokinetic Prediction-Commentary Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction
    Mao, Qingcheng
    Lai, Yurong
    Wang, Joanne
    DRUG METABOLISM AND DISPOSITION, 2018, 46 (05) : 561 - 566
  • [49] SAMPLING FREQUENCY TO DESCRIBE DRUG DISPOSITION IN NEONATES
    GAL, P
    KANDROTAS, RJ
    JOURNAL OF PEDIATRICS, 1988, 112 (06): : 1048 - 1049
  • [50] Population pharmacokinetic analyses and neonates: An overview
    Marsot, A.
    Boulamery, A.
    Bruguerolle, B.
    Simon, N.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2012, 26 : 118 - 118
12345